Skip to main content
SpringerLink
Log in

Nine-valent HPV vaccine cost effective in children?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ng SS, et al. Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination. Vaccine : 3 Apr 2018. Available from: URL: http://doi.org/10.1016/j.vaccine.2018.03.024

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nine-valent HPV vaccine cost effective in children?. PharmacoEcon Outcomes News 801, 26 (2018). https://doi.org/10.1007/s40274-018-4881-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4881-7

Search

Navigation